Table II.
ANGPTL4 expression, n | |||||
---|---|---|---|---|---|
Variable | Negative | Weakly positive | Moderately positive | Strongly positive | P-value |
Age, years | 0.371 | ||||
<55 | 38 | 28 | 30 | 12 | |
≥55 | 37 | 25 | 22 | 13 | |
Tumor size, cm | <0.001 | ||||
≤2.0 | 46 | 10 | 15 | 7 | |
2.1–5.0 | 29 | 41 | 30 | 8 | |
>5.0 | 0 | 2 | 7 | 10 | |
pTNM | <0.001 | ||||
I | 30 | 6 | 4 | 0 | |
II | 29 | 38 | 28 | 7 | |
III | 16 | 7 | 14 | 12 | |
IV | 0 | 2 | 6 | 6 | |
Grade | <0.001 | ||||
I | 25 | 8 | 4 | 0 | |
II | 34 | 31 | 31 | 15 | |
III | 16 | 14 | 17 | 10 | |
ER | 0.955 | ||||
– | 38 | 29 | 28 | 12 | |
+ | 37 | 24 | 24 | 13 | |
PR | 0.793 | ||||
– | 41 | 30 | 22 | 18 | |
+ | 34 | 23 | 30 | 7 | |
HER2 | 0.211 | ||||
– | 35 | 32 | 22 | 9 | |
1+ | 16 | 5 | 18 | 8 | |
2+ | 14 | 4 | 6 | 4 | |
3+ | 10 | 12 | 6 | 4 | |
Lymph node metastasis | <0.001 | ||||
– | 51 | 29 | 25 | 6 | |
+ | 24 | 24 | 27 | 19 | |
Distant metastasis | <0.001 | ||||
– | 68 | 46 | 37 | 15 | |
+ | 7 | 7 | 15 | 10 | |
Local recurrence | |||||
– | 75 | 51 | 48 | 19 | <0.001 |
+ | 0 | 2 | 4 | 6 |
ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; ANGPTL4, angiopoietin-like 4.